Metabolism in Preimplantation Mouse Embryos by Weitlauf, Harry M. & Nieder, Gary L.
Wright State University 
CORE Scholar 
Neuroscience, Cell Biology & Physiology Faculty 
Publications Neuroscience, Cell Biology & Physiology 
7-1984 
Metabolism in Preimplantation Mouse Embryos 
Harry M. Weitlauf 
Gary L. Nieder 
Wright State University - Main Campus, gary.nieder@wright.edu 
Follow this and additional works at: https://corescholar.libraries.wright.edu/ncbp 
 Part of the Medical Cell Biology Commons, Medical Neurobiology Commons, Medical Physiology 
Commons, Neurosciences Commons, and the Physiological Processes Commons 
Repository Citation 
Weitlauf, H. M., & Nieder, G. L. (1984). Metabolism in Preimplantation Mouse Embryos. Journal of 
Biosciences, 6 (Supplement 2), 33-42. 
https://corescholar.libraries.wright.edu/ncbp/418 
This Article is brought to you for free and open access by the Neuroscience, Cell Biology & Physiology at CORE 
Scholar. It has been accepted for inclusion in Neuroscience, Cell Biology & Physiology Faculty Publications by an 
authorized administrator of CORE Scholar. For more information, please contact library-corescholar@wright.edu. 





Metabolism in preimplantation mouse embryos
 
 
H. M. WEITLAUF and G. L. NIEDER
Department of Anatomy, Texas Tech University School of Medicine, Lubbock, Texas 79430, 
USA 
 
Abstract. The ability of preimplantation mouse embryos to utilize glucose oxidatively is 
controlled, in part at least, at the level of glycolysis. Various experimental observations are 
reviewed that indicate the regulatory mechanism in delayed implanting blastocysts involves 
the classic negative allosteric feedback of high levels of ATP on phosphofructokinase while the 
situation in 2-cell embryos appears to be more complicated. That is, in addition to the usual 
negative effect of ATP and citrate on phosphofructokinase, there appears to be a modification 
of hexokinase that prevents phosphorylation of adequate amounts of glucose and results in 
low levels of fructose-6-phosphate at the 2-cell stage and consequently there is a failure to 
release the inhibition of phosphofructokinase even if ATP and citrate levels decrease. 
Although both types of embryos have limited glycolytic activity, they do have adequate 
capacity for citric acid cycle activity and oxidative phosphorylation, and are able to maintain a 
high ATP : ADP. It is argued, therefore, that the reduced levels of macromolecular synthesis 
characteristic of 2-cell and delayed implanting blastocysts are not due to restricted energy 
substrates or regulatory controls on glycolysis and a subsequent low energy state. On the 
contrary, it seems that the reduction in oxidative utilization of glucose in these situations is a 
result of diminished energy demand because of the low level of synthetic activity. The potential 
significance of this relationship between energy production and utilization in terms of 
potential regulatory mechanisms in preimplantation embryos is discussed.
 





Interest in the capacity of mammalian preimplantation embryos to utilize various 
energy substrates was initiated by Whitten's (1956, 1957) observations that mouse 
embryos at the 8-cell stage would develop in a Krebs-Ringer bicarbonate solution 
containing albumin and glucose while 2-cell embryos required the addition of lactate. 
This demonstration of a difference in substrate requirements led to the realization that 
there are changes in the metabolic capacity of mammalian preimplantation embryos 
with development, and suggested that some regulatory mechanism must function even 
in these very early stages. Although a great deal of information about the metabolic 
capabilities of early mammalian embryos has been generated in the 25 years since 
Whitten's original observations, and some control mechanisms have been elucidated 
(Biggers, 1971; Wales, 1973,1975), the significance of changes in substrate utilization is 
still not entirely clear. The purpose of this communication is to review some of the work 
that has been done with normal and delayed implanting embryos in an attempt to 
identify questions that remain unanswered. 
 
Abbreviations used: CoA, Coenzyme A; Pi , orthophosphate. 
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Cleavage stage embryos 
 
Almost ten years after Whitten's original papers, Brinster (1965) reported the results of 
a systematic study undertaken to evaluate the effects of a wide variety of potential 
energy substrates on development of 2-cell mouse embryos in vitro. He found that 
development would occur if the embryos were supplied with lactate, pyruvate, 
oxaloacetate, or phosphoenolpyruvate, but not if they were given acetate, citrate, 
α-ketoglutarate, succinate, fumarate, malate, or glucose. In further studies by Brinster 
and his colleagues utilization of O2 was measured (Mills and Brinster, 1967), and it was 
demonstrated that lactate and pyruvate could be oxidized equally as well by 2-cell and 
8-cell embryos (Brinster, 1967a) while Quinn and Wales (1973a,b) reported that these 
same substrates would maintain normal levels of ATP in both 2-cell and 8-cell embryos. 
These findings have been taken as indicating that enzyme systems necessary for citric 
acid cycle activity and oxidative phosphorylation are intact and functional even in 2-cell 
embryos. The assumption then, has been that glucose and those citric acid cycle 
intermediates that do not support development of the early embryos, either cannot 
enter the cells or cannot be converted to a substrate that will support continued 
operation of the citric acid cycle.
Embryos develop the capacity to use other substrates between the 2-cell and the 
8-cell stages (Brinster and Thomson, 1966) and most attention in this regard has been 
directed at malate and glucose. Wales and Biggers (1968) were unable to 
demonstrate either accumulation of labelled carbon or evidence of oxidative utilization 
of U-[14C]-malate by 2-cell embryos in contrast to 8-cell embryos and concluded that 
absence of a transport mechanism for malate was, in the early stage, responsible. It 
should be noted however, that initial rates of uptake of malate were not determined in 
those studies and therefore, that changes in permeability were not measured directly. 
Another argument for there being a change in the capacity of embryos to take up malate 
has been developed from data generated in several different experiments. First, it will be 
recalled that 2-cell embryos develop in vitro with oxaloacetate but not malate as the sole 
source of energy supplied to the medium (Brinster, 1965); and, second, that 2-cell 
embryos have NAD+ dependent malate dehydrogenase activity (Brinster, 1966) and 
thus should be able to convert malate to oxaloacetate. Although it seems from this that 
malate should support early embryos if it could enter the cells, one further point must 
be considered; oxaloacetate cannot be used directly to support continued operation of 
the citric acid cycle, rather it must be converted to acetyl-coenzyme A presumably 
through the formation of pyruvate. Although this does not appear to have always been 
appreciated (Biggers et al., 1967), it raises the question of whether the conversion occurs 
intracellularly and if so, by means of which enzymatic pathway and in which cellular 
compartment? There are several possibilities (figure 1): Oxaloacetate might enter the 
cells and be converted to pyruvate in the cytoplasm; this would presumably require 
formation of phosphoenolpyruvate (i.e., via phosphoenolpyruvate carboxykinase) and 
then pyruvate (i.e., via pyruvate kinase); this scheme seems reasonable although neither
of the enzymes necessary for these transformations have been demonstrated at early 
stages of development. It is also possible that oxaloacetate is reduced to malate in the 
cytoplasm (malate dehydrogenase activity has been demonstrated at the 2-cell stage; 
Brinster, 1966; Quinn and Wales, 1971) and then goes on to pyruvate (i.e., also in the
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cytoplasm via malic enzyme; the presence of malic enzyme has been demonstrated 
(Quinn and Wales, 1971). Alternatively, malate from the cytoplasm might enter the 
mitochondria (malate, but not oxaloacetate, can cross the mitochondrial membrane), 
be converted back to oxaloacetate, and then on to pyruvate (i.e., by way of the 
mitochondrial enzyme pyruvate carboxylase). Enzyme activities necessary for these 
mitochondrial conversions have been demonstrated in early mouse embryos (Quinn 
and Wales, 1971). Although this scheme might seem unlikely because it would 
eventually lead to a deficiency of reducing equivalents in the cytoplasm, it is compatible 
with Thomson's (1967) finding that malonate (an inhibitor of pyruvate carboxylase) 
will block development of 2-cell embryos supplied with oxaloacetate but not those 
given pyruvate. Thomson's (1967) observation also argues against the possibility that 
oxaloacetate is able to support development only because it spontaneously breaks 
down to pyruvate in the medium. Thus, although it is not clear how oxaloacetate is 
utilized, it has generally been assumed that it supports the citric acid cycle either directly 
(Biggers et al., 1967), or after being converted intracellularly to pyruvate by way of one 
or another of the schemes outlined above. From this assumption it has been argued that 
there are changes in transport of malate with development. The reasoning is as follows: 
since the enzymatic capability to convert malate to oxaloacetate is present at the 2-cell 
stage, the inability of malate to support development at that stage indicates it is not able 
to enter embryos. That malate is capable of supporting 8-cell embryos then, indicates 
that capacity for its transport develops at that stage. It must be emphasized that this 
does not constitute a rigorous proof of a change in permeability, nor has the possibility 
that malate can enter 2-cell embryos but for some reason is not converted to 
oxaloacetate or pyruvate (possibly the absence of malic enzyme or a high NADH to 
NAD+ ratio) been considered. These questions will have to be resolved before the 
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problem of why some citric acid cycle intermediates will support early development, 
and others will not, can be answered definitively.
Utilization of glucose by 2-cell embryos has been examined in detail and although it 
is apparently involved in synthesis of glycogen and other macromolecules (Stern and 
Biggers, 1968; Brinster, 1969; Murdoch and Wales, 1973; Wales, 1975), it is not oxidized 
to any great extent (Brinster, 1967b) and will not maintain normal levels of ATP (Quinn 
and Wales, 1973b). Glucose will, however, support development of 8-cell embryos 
(Brinster, 1965) and again it has been proposed that this is because of changes either in 
enzyme pathways (in this case Embden-Myerhoff scheme), or in the embryo's capability 
to transport the substrate. The observation by Wales and Brinster (1968) that 2-cell 
and 8-cell embryos incubated in 5·1 mM U-[14C]-glucose accumulate labelled carbon 
at equal rates in the first 3 min supports the suggestion that it is regulation of glycolysis 
rather than uptake that is responsible for the inability of glucose to support the early 
embryos. However, changes in glucose transport between the 2-cell and 8-cell stage 
have not been conclusively ruled out. More recently, the various intermediates in 
glycolysis have been measured in 2-cell, 8-cell, and later stage embryos during 
starvation and refeeding with glucose or pyruvate (Barbehenn et al., 1974, 1978). 
Glucose-6-phosphate, fructose-6-phosphate, fructose-1,6-bisphosphate, ATP, AMP,
orthophosphate (Pi), citrate, isocitrate, malate and α-ketoglutarate were measured and 
it was found that there is a "block" at the phosphofructokinase step in 2-cell embryos. 
Although phosphofructokinase is allosterically inhibited by high levels of citrate and 
ATP in many systems, the block is characteristically lost under anaerobic conditions as 
levels of citrate and ATP fall (i.e., the Pasteur effect). This does not seem to be the case in 
starved 2-cell embryos where citrate and ATP levels also fall, since phosphofructo- 
kinase activity remains low during refeeding with glucose. Furthermore, it appeared 
that the potential for adequate hexokinase activity was present in the early embryos 
(i.e., when measured in cell lysates), but maximum levels of the hexosephosphates after 
refeeding were lower in the early stages than they were in the later stages. This was 
interpreted as indicating that for some unknown reason glucose phosphorylation is 
shut off in 2-cell embryos by a low level of glucose-6-phosphate and thus, only a low 
level of fructose-6-phosphate is attained. Since fructose-6-phosphate can potently 
release the inhibition of phosphofructokinase, it was proposed that an increase in that 
compound at a later stage is the major cause of the greater phosphofructokinase 
activity and hence glycolysis. Although it was concluded that the true cause of the 
inability of 2-cell embryos to utilize glucose is an "unknown modification" of the initial 
enzymes in the glycolytic scheme (i.e., hexokinase, Barbehenn et al., 1978), no definitive
explanation has been offered.
Studies such as these have added greatly to our understanding of metabolism in early 
embryos but they have not provided satisfactory answers to the original question of 
whether it changes in transport or enzyme pathways that are primarily responsible 
for differences in the ability of glucose and various citric acid cycle intermediates to 
support development at the 2-cell and 8-cell stages of development. Furthermore, 
although we know that the level of macromolecular synthesis is low in these early 
embryos, and that as a consequence ATP levels are relatively high, we do not have any 
information on the significance of putative changes in pathways for various energy 
intermediates to embryos that are normally in an environment that is rich in pyruvate 
(Nieder and Corder, 1983).
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Delayed implanting embryos 
 
Development of mouse embryos is arrested at the blastocyst stage in mothers that are 
concurrently lactating (lactational delayed implantation) or are ovariectomized before 
noon on the fourth day of pregnancy (experimentally delayed implantation). Although 
it has been known for some time that metabolic and mitotic activity in these embryos 
decreases until the suckling young are removed or estrogen is injected into the mother 
(McLaren and Menke, 1971; McLaren, 1973), and many reports have appeared that 
deal with metabolic activity and synthesis of macromolecules, there has not really been 
a satisfactory explanation, at the molecular level, for the embryonic quiescence 
associated with delayed implantation. Typically in these experiments, embryos are 
recovered from the uteri of mice that have been ovariectomized and treated with 
progesterone for several days and incubated in vitro with radioactive precursor 
molecules. Utilization or incorporation of label into DNA, RNA, or protein is then 
estimated by scintillation counting or autoradiographic techniques. The findings can be 




Incorporation of [3H]-thymidine slows (and finally ceases altogether) as embryos enter 
the dormant phase associated with lactational delayed implantation (McLaren, 1968). 
This occurs in the 24–30 h following removal of the maternal ovaries in experimental 
delayed implantation (Given, 1983; Given and Weitlauf, 1981) and might have been 
anticipated as the cells become arrested in the G1 phase of the cell cycle (Sherman and 
Barlow, 1972); the level of mitotic activity has been shown to decrease over the same 
interval by direct cell counts (Weitlauf et al., 1979). Furthermore, reactivation of the 
embryos by injecting estrogen into the mother (or simply removing them from the 
uterus to appropriate culture conditions), leads to a resumption of [3H]-thymidine 
incorporation (Given and Weitlauf, 1981, 1982) and cell division (Weitlauf et al., 1979). 
Taken alone, the changes in incorporation of labelled thymidine might be interpreted as 
reflecting changes in permeability or specific activities of internal precursor pools. But 
taken in conjunction with the fact that there are corresponding changes in cell division 
and the observation that the cells are in G1 during the dormant period, it seems clear 
that the reported changes in rates of incorporation of [3H]-thymidine actually reflect 




Several investigators have compared the incorporation of [3H]-uridine by delayed 
implanting blastocysts with that by embryos implanting normally or undergoing the 
process of reactivation. Typically, blastocysts were recovered from the uteri of 
ovariectomized females and incubated in vitro with [3H]-uridine and it was observed 
that the rate of incorporation of label into RNA was lower in delayed implanting 
embryos than that in normal or reactivated embryos (Weitlauf, 1976; Chavez and 
VanBlerkom, 1979). However, because the specific activities of the endogenous pools of 
UTP were not known the actual rates of RNA synthesis could not be determined in 
those experiments and there has been disagreement over interpretation of the results. 
More recently a similar series of experiments was performed and the specific activities 
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of the endogenous pools of UTP were determined and the actual rates of synthesis of 
RNA could be calculated from the rates of incorporation of [3H]-uridine (Weitlauf 
and Kiessling, 1980). In this way, after correcting for differences in numbers of cells it 
was shown that the overall rate of synthesis of RNA in delayed implanting embryos is 
about one-third of that in reactivated embryos. It was also shown that the increases in 
synthesis of RNA that occurred with reactivation took place gradually over 12–24 h in 
vitro. A similar change in synthesis of RNA has been shown to occur in vivo following 
the injection of estrogen into the mother (Weitlauf, 1982). Furthermore, in that 
experiment it was shown that although the bulk of the increase in [3H]–uridine 
incorporation was into rRNA, there was a transient burst of mRNA synthesis early in 
the process of reactivation (i.e., 3–4 h after the injection of estrogen). Although these 
results with RNA are reminiscent of those with DNA, it should be noted that in contrast 
to that situation, the embryos do not completely stop synthesis of RNA during delayed 
implantation. Rather, they continue to operate at approximately one-third of the level 





The rate of incorporation of labelled amino acids into protein by delayed implanting 
mouse embryos is about half that observed in normal implanting or reactivated 
embryos; it increases to normal levels within a few hours of the injection of estrogen or 
removal of the blastocysts from the uterus to a suitable culture medium (Weitlauf, 
1974; VanBlerkom et al., 1979). Although the effects of potential differences in specific 
activities of intracellular amino acid pools have not been rigorously evaluated, it has 
been shown that total protein content changes proportionately with the incorporation 
of radioactive amino acids (Weitlauf, 1973) and the estimates of protein synthetic rates 
from incorporation of label would seem to be valid. Although it is clear from such 
observations that the rate of protein synthesis in delayed implanting embryos is low and 
that it increases with reactivation, the unanswered question is whether this involves 
transcription of specific new mRNA or a more generalized change in metabolic activity 
and rates of translation. It would be expected that the mechanisms responsible for the 
developmental arrest associated with delayed implantation will be quite different, 
depending on which of these strategies has been employed by the embryos. Several 
relevant observations have been made but the question remains unanswered. Thus, 
two-dimensional electrophoresis has revealed that some 'new' proteins can be 
demonstrated in the first few hours of the reactivation process (VanBlerkom et al., 
1979); unfortunately, it is not clear whether these "spots" are truly new proteins and 
thus reflect synthesis of new mRNA or simply represent increases in amounts of 'old' 
proteins that become visible because of increased rates of synthesis. Attempts to block 
the process of activation in vitro with α-amanitin (i.e., at doses that would be expected to 
block synthesis of new mRNA) do not completely prevent the expected increases in 
incorporation of amino acids (unpublished results). The difficulty with this approach is, 
that because it is total incorporated radioactivity that is measured, one cannot 
determine if small changes in synthesis of specific proteins have occurred. Finally, it has 
been reported that the amounts of some enzymes increase, others remain the same, or 
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even decrease with activation (Weitlauf et al., 1979; Weitlauf, 1981; Nieder and 
Weitlauf, 1983), again suggesting that there are some differential changes in protein 
synthesis. However, it must be emphasized that such changes could reflect either 
transcriptional or translational mechanisms. Thus, the question of how macro- 





In addition to the studies on macromolecular synthesis there have been numerous 
experiments directed to utilization of glucose as an energy substrate. The original 
observations were those of Menke and McLaren (1970a,b; Menke, 1972) that 
demonstrated the production of 14CO2 from U-[14C]-glucose was reduced in delayed 
implanting embryos. In these experiments again, blastocysts were recovered and 
incubated with labelled substrate and radioactive product generated with time was 
evaluated by scintillation counting procedures. These studies were followed up with the 
observation that during activation of the dormant embryos the rate of glucose 
oxidation increases and that this occurred whether the process was in vivo with estrogen 
or in vitro (Torbit and Weitlauf, 1974,1975). Although these studies also suffered from 
potential questions about permeability and specific activity of endogenous pools, they 
raised the possibility that decreased energy production might lead to a reduction in 
synthesis of macromolecules and ultimately, the metabolic quiescence that seems to be 
responsible for the developmental arrest associated with delayed implantation. This 
scheme would implicate the regulation of energy production as a prime control in 
development of preimplantation embryos. Two other observations have tended to 
reinforce this idea: (i) Nilsson and his co-workers (Nilsson et al., 1982) measured 
utilization of O2 by delayed implanting embryos and found it to be decreased. 
Although this might have been expected from the studies showing reduced oxidative 
utilization of glucose, it was significant because he measured absolute consumption of 
O2 and did not depend on the use of radioisotopes. This approach, then, is not open to 
questions about specific activity, permeability, etc. In the same report it was also noted 
that cytochrome oxidase activity was decreased in delayed implanting embyros and 
suggested that the lower oxidative utilization of glucose is due to a reduced capacity for 
oxidative phosphorylation and leads to decreased energy production, (ii) Embryos do 
not develop beyond the blastocyst stage if glucose is missing from the medium 
(Wordinger and Brinster, 1976; Naeslund, 1979; VanBlerkom et al., 1979). It has been 
suggested that this may be equivalent to embryonic diapause in vitro and that 
restriction of glucose in the uterine lumen might actually lead to the arrested 
development in delayed implantation. Again the underlying idea here is that a lack of 
energy production is responsible, at least in part, for the quiescence associated with 
delayed implantation. 
Although it seems clear from some of this work that utilization of glucose is reduced 
in delayed implanting embryos, two questions that need to be answered are: (i) what 
step in the metabolic scheme for glucose is regulated?, and (ii) whether the associated 
reduction in energy production is responsible for the decrease in macromolecular 
synthesis? 
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Glycolysis and oxidative phosphorylation 
 
The observation by Menke and McLaren (1970a,b) that oxidative utilization of glucose 
is decreased in delayed implantation, along with the report by Nilsson and his co- 
workers (Nilsson et al., 1982) that there is a reduction in cytochrome oxidase activity, 
suggests that oxidative phosphorylation is limited in delayed implantation. Further, it 
has been proposed that it is the resulting inability of the embryos to generate sufficient 
amounts of energy that leads to the reduction in macromolecular synthesis and the 
characteristic developmental arrest (Nilsson et al., 1982). To test this hypothesis, 
experiments were undertaken in our laboratory to measure the capacity for citric acid 
cycle activity and oxidative phosphorylation in intact delayed implanting mouse 
embryos (Nieder and Weitlauf, 1983). (i) Dormant and reactivated embryos were 
recovered and incubated with 2-[14C] -pyruvate; evolved 14CO2 was trapped, and the 
amount of radioactivity was measured. After correcting for differences in embryonic 
mass, it was found that the ability to utilize pyruvate oxidatively was equal in the two 
types of embryos (74 ± 11 and 72 ± 9 pmol CO2/h/µ g respectively). This result 
demonstrated that failure of delayed implanting embryos to oxidize glucose is not due 
to deficiencies in the citric acid cycle or oxidative phosphorylation and suggests either 
uptake of glucose or enzymatic regulation in the Embden-Meyerhoff scheme as 
possible control points. (ii) To avoid the questions raised by utilization of labeled 
substrates in testing the glycolytic pathway, embryos were recovered and placed in vitro 
in medium containing non-labelled glucose and the production of lactate (i.e., in the 
presence of O2) over 2 h was measured. It was found that active embryos produced more 
lactate than delayed implanting embryos (92 ± 5, and 45 ± 4 pmol CO2/h/µg respect- 
ively), thus confirming that uptake of glucose or the glycolytic pathway are restricted in 
the dormant embryos, (iii) The amounts of phosphofructokinase and hexokinase 
activity were measured in lysed embryos to determine if the levels of these primary 
regulatory enzymes could be responsible for reduced glycolytic activity. The levels of 
phosphofructokinase were not different in dormant and reactivated embryos (80·4 
± 8·9, 72·5 ± 6·3 pmol/min/µ g respectively). Interestingly, the level of hexokinase 
activity in the delayed implanting embryos was nearly 3 times that in the active embryos 
(i.e., 21·7 ± 2·1, and 6·5 ± l·2 pmol/min/µg respectively), thus demonstrating that 
absolute amounts of these regulatory enzymes are not limiting in the dormant embryos. 
(iv) Transport of glucose into blastocysts was examined by measuring the initial rates of 
uptake and phosphorylation of [3H]-2-deoxyglucose at varying concentrations. The 
Km for the substrate was not significantly different in the two types of embryos but 
surprisingly the Vmax for dormant embryos was 2·2 times higher than that for the active 
embryos. This result demonstrates that the capacity for uptake and phosphorylation of 
glucose are not restricting in delayed implantation, (v) That glucose utilization by 
delayed implanting embryos is low in spite of the fact that the embryos have sufficient 
enzymes to maintain glucose uptake and glycolysis, as well as the capacity for normal 
citric acid cycle activity and oxidative phosphorylation of pyruvate, suggests that there 
is a negative regulatory control of glycolysis. To pursue this possibility lactate 
production was examined in anaerobic conditions designed to elicit, if possible; a 
Pasteur effect that would confirm the presence of negative allosteric feedback in the 
delayed implanting blastocysts. Embryos were incubated in medium with cold glucose 
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in the absence of O2 (i.e., an atmosphere of N2); lactate production by dormant and 
active embryos over 2 h was increased several fold over that seen in the presence of O2 
(i.e., confirming a Pasteur effect) and was not different in the two types of embryos (i.e.,
862 ± 82, and 906 ± 75 pmol/h/µg respectively). From this result it is clear that the two 
types of embryos have an equal capacity for glycolysis and that some form of negative 
allosteric feedback is responsible for regulating the Embden-Meyerhoff pathway, (vi) 
Several metabolites known to modulate the rate of glycolysis were then measured; ATP 
levels were found to be approximately 2-fold higher while ADP levels were 3-fold lower 
in delayed implanting (i.e., compared to activated) embryos (i.e., 16·5 ± 2·5 and 7·9
± l·0 pmol ATP/µg, and 3·1 ± 3·8 and 9·6 ± l·6 pmol ADP/µg respectively). 
Hexosephosphates were also measured and found to be much higher in dormant than 
in activated embryos (i.e., the level of combined glucose-6-phosphate and fructose-6- 
phosphate was 5·25 ± 0·56 and 1·14 ± 0·22 pmol/µg respectively). The buildup of these 
metabolites along with the high ATP : ADP suggest that phosphofructokinase is the 
regulated step in glycolysis and that the regulatory mechanism is the classic negative 
allosteric feedback described in numerous other systems. These results demonstrate 
that although the failure of delayed implanting embryos to utilize glucose oxidatively 
must result in a low rate of energy production, it is not responsible for the characteristic 
reduction in synthesis of macromolecules. On the contrary, it appears that reduced 
demand for energy is a result of decreased macromolecular synthesis and that the 





Although it has been possible to elucidate some of the control mechanisms for glucose 
metabolism in 2-cell mouse embryos and delayed implanting blastocysts, their 
significance is not clear. Indeed, since the embryos at both of these stages have a high 
ATP : ADP and are probably bathed in pyruvate (Nieder and Corder, 1983) in the 
reproductive tract anyway, it is not likely that regulation of glycolysis, the availability of 
glucose, or changes in the capacity to utilize various metabolic intermediates would 
have important roles in controlling development of preimplantation embryos. If the 
great question in development is what regulates differentiation, the question in 
preimplantation biology must be how can the mother cause differentiation of the 
embryo to stop and restart at a later time as occurs with delayed implantation? The 
implication of the work reviewed above is that the mechanism probably involves 
control at the level of embryonic transcription or translation and not inhibition of 
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